2,3:5,6-di-O-isopropylidene-1-O-{2-[1-(4-{2-[4-chloro-phenoxy]-acetyl}-piperazinyl)]-ethyl}-α-D-mannofuranoside

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2,3:5,6-di-O-isopropylidene-1-O-{2-[1-(4-{2-[4-chloro-phenoxy]-acetyl}-piperazinyl)]-ethyl}-α-D-mannofuranoside
• 英文别名: 2.3:5.6-di-O-isopropylidene-1-O-{2-[1-(4-{2-[4-chloro-phenoxy]-acetyl}-piperazinyl)]-ethyl}-α-D-mannofuranoside；2,3;5,6-di-O-isopropylidene-1-O-{2-[1-(4-{2-[4-chlorophenoxy]-acetyl}-piperazinyl)]-ethyl}-α-D-mannofuranoside；1-[4-[2-[[(3aS,4S,6R,6aS)-6-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]oxy]ethyl]piperazin-1-yl]-2-(4-chlorophenoxy)ethanone
• 化学式: C₂₆H₃₇ClN₂O₈
• 分子量: 541.041
• InChiKey: LUMFVTFFVOUBAZ-AZKGINQHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  37
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  88.2
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  1-O-(2-chloroethyl)-2,3:5,6-di-O-isopropylidene-α-D-mannofuranoside 在 potassium carbonate 、 caesium carbonate 、 三乙胺 、 potassium iodide 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 2,3:5,6-di-O-isopropylidene-1-O-{2-[1-(4-{2-[4-chloro-phenoxy]-acetyl}-piperazinyl)]-ethyl}-α-D-mannofuranoside
  参考文献：
  名称：

  MONOSACCHARIDE DERIVATIVES

  摘要：

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了包含本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。

  公开号：

  US20080114031A1

文献信息

• Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents
  申请人：Sattigeri Vishwajanani Jitendra

  公开号：US20090048186A1

  公开（公告）日：2009-02-19

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了含有本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。
• MONOSACCHARIDE DERIVATIVES AS ANTI-INFLAMMATORY AND/OR ANTI-CANCER AGENTS
  申请人：Ranbaxy Laboratories Limited

  公开号：EP1842855A3

  公开（公告）日：2007-12-05

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, psoriasis, allograft rejection, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎药物。本文中所述的化合物可用于抑制和预防炎症及相关病理，包括支气管哮喘、类风湿关节炎、1型糖尿病、多发性硬化症、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎等炎症和自身免疫性疾病。还提供了含有本文披露的化合物的药理组合物以及治疗支气管哮喘、慢性阻塞性肺病、类风湿关节炎、多发性硬化症、1型糖尿病、牛皮癣、移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎和其他炎症和/或自身免疫性疾病的方法。
• WO2006/111783
  申请人：——

  公开号：——

  公开（公告）日：——
• [EN] MONOSACCHARIDE DERIVATIVES AS ANTI-INFLAMMATORY AND/OR ANTI-CANCER AGENTS<br/>[FR] DERIVES DE MONOSACCHARIDES UTILES COMME AGENTS ANTI-INFLAMMATOIRES ET/OU ANTICANCEREUX
  申请人：RANBAXY LAB LTD

  公开号：WO2006111783A1

  公开（公告）日：2006-10-26

  [EN] The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.
  [FR] La présente invention porte sur des dérivés de monosaccharides utiles comme agents anti-inflammatoires. Les composés de cette invention peuvent être utiles dans l'inhibition et la prévention d'inflammations et de pathologies associées, y compris les maladies inflammatoires et auto-immunes, telles que l'asthme bronchique, l'arthrite rhumatoïde, le diabète de type I, la sclérose en plaques, le rejet d'allogreffe, le psoriasis, les maladies intestinales inflammatoires, la colite ulcéreuse, l'acné, l'athérosclérose, le cancer, le prurit et la rhinite allergique. L'invention porte également sur des compositions pharmacologiques contenant ces composés et sur des méthodes de traitement de l'asthme bronchique, des maladies pulmonaires obstructives chroniques, de l'arthrite rhumatoïde, de la sclérose en plaques, du diabète de type I, du psoriasis, du rejet d'allogreffe, des maladies intestinales inflammatoires, de la colite ulcéreuse, de l'acné, de l'athérosclérose, du cancer, du prurit, de la rhinite allergique et autres maladies inflammatoires et/ou auto-immunes utilisant les composés.